Loading...

OTC Markets

Totals

Securities

12,313

Dollar Vol

$1.5B

Share Vol

1.7B

Trades

201,159

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
BIIB
Financials

BIIB
Biogen Inc.

Common Stock

130.00

-3.11

-2.34%

Delayed (15 Min) Trade Data: 12:52pm 07/15/2025

Financials

Fiscal year ends 12/31

| Values in 000s USD

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Invalid date

12/30/2024

Invalid date

12/30/2023

Invalid date

12/30/2022

Invalid date

12/30/2021

2024-12-31 00:00:00

2023-12-31 00:00:00

2024-12-31 00:00:00

2022-12-31 00:00:00

2024-12-31 00:00:00

2021-12-31 00:00:00

2024-12-31 00:00:00

Revenues

Total Revenue

9,675,900

9,835,600

9,675,900

10,173,400

9,675,900

10,981,700

9,675,900

Cost of Revenue

2,310,400

2,533,400

2,310,400

2,278,300

2,310,400

2,109,700

2,310,400

Gross Profit

7,365,500

7,302,200

7,365,500

7,895,100

7,365,500

8,872,000

7,365,500

Operating Expenses

Research and Development

2,041,800

2,462,000

2,041,800

2,231,100

2,041,800

2,501,200

2,041,800

Sales, General and Admin

2,403,700

2,549,700

2,403,700

2,403,600

2,403,700

2,674,300

2,403,700

Non-Recurring Items

30,200

218,800

30,200

131,100

30,200

18,000

30,200

Other

728,800

459,400

728,800

149,400

728,800

837,800

728,800

Total Expenses

5,204,500

5,689,900

5,204,500

4,915,200

5,204,500

6,031,300

5,204,500

Operating Income

2,161,000

1,612,300

2,161,000

2,979,900

2,161,000

2,840,700

2,161,000

Income from Continuing Operations

Additional Income / Expense Items

(343,600)

(315,500)

(343,600)

108,200

(343,600)

(1,095,500)

(343,600)

Earnings Before Interest and Taxes

2,161,000

1,612,300

2,161,000

2,979,900

2,161,000

2,840,700

2,161,000

Interest Expense

Earnings Before Tax

1,906,000

1,296,800

1,906,000

3,591,800

1,906,000

1,745,200

1,906,000

Income Tax

273,800

135,300

273,800

632,800

273,800

52,500

273,800

Minority Interest

(400)

87,900

(136,600)

Equity Earnings

2,600

34,900

Net Income Cont. Operations

1,632,200

1,161,100

1,632,200

3,046,900

1,632,200

1,556,100

1,632,200

Non-Recurring Events

Discontinued Operations

Extraordinary Operations

Effect of Accounting Changes

Net Income

1,632,200

1,161,100

1,632,200

3,046,900

1,632,200

1,556,100

1,632,200

Key Financial Ratios

Earnings Per Share

11.21

8.02

11.21

20.96

11.21

10.44

11.21

Price/Earnings

13.6414

Gross Margin

0.7612

0.7424

0.7612

0.776

0.7612

0.8079

0.7612

Operating Margin

0.2233

0.1639

0.2233

0.2929

0.2233

0.2587

0.2233

Financial data presented is provided by Edgar Online and may differ from information contained in the issuer's annual and periodic reports, which are available under the "Disclosure" tab.

Neither the issuer nor OTC Markets Group is liable for any errors, omissions or other defects in the data presented below, or for any decisions taken in reliance of the data.

For information not originally reported in U.S. Dollars, conversion is based on applicable exchange rate on the last day of the period reported.

© 2025 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Market Groups Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.

Nasdaq

Daily Advancers